SCHEMBL23362168

SCHEMBL23362168

Nc1nc2ccc(F)cc2n1Cc1cccc(OC(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 3/20 0.45
▸ HTT P42858 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ GRIN1 Q05586 2/20 0.41
▸ GRIN2B Q13224 2/20 0.41
▸ P2RX3 P56373 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ TNIK Q9UKE5 1/20 0.41
▸ BRD4 O60885 1/20 0.40
▸ SOS1 Q07889 1/20 0.40
▸ FEN1 P39748 1/20 0.40
▸ MPO P05164 1/20 0.40
▸ SLC2A1 P11166 1/20 0.40
▸ SLC2A3 P11169 1/20 0.40
▸ SLC2A4 P14672 1/20 0.40
▸ HCRTR1 O43613 1/20 0.39
▸ HCRTR2 O43614 1/20 0.39
▸ KCNK13 Q9HB14 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23361958 0.91 ALDH1A1 (0.50) CSF1RHTTALDH1A1POLBGRIN1
SCHEMBL23361862 0.87 CSF1R (0.57) CSF1RHTTALDH1A1POLBKMT2A
SCHEMBL23361807 0.87 POLB (0.57) CSF1RHTTALDH1A1POLBGRIN2B
SCHEMBL23361964 0.80 POLB (0.69) CSF1RHTTALDH1A1POLBGRIN2B
SCHEMBL990644 0.74 HTT (0.66) CSF1RHTTALDH1A1POLBKMT2A
SCHEMBL17487443 0.74 TYMS (0.47) CSF1RHTTALDH1A1POLBGRIN1
SCHEMBL4083456 0.73 PPARG (0.47) HTTPOLBKMT2ATSHR
SCHEMBL23361809 0.71 CSF1R (0.76) CSF1RHTTALDH1A1POLBKMT2A
SCHEMBL22726431 0.69 MCHR1 (0.55) ALDH1A1POLBTSHR
SCHEMBL20715421 0.69 HTR3A (0.53) SOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021096314-A1 NOVEL BENZIMIDAZOLE DERIVATIVE AND USE THEREOF 가천대학교 산학협력단 2021-05-20 — — WO disclosed
Send feedback